Abbott Architect i1000 Reagents
Updated
Solicitation from the Department of Veterans Affairs, for work in Tucson, Arizona. Due Nov 13, 2026, 1:00 AM (UTC-8), 2 days left.
| Title as posted | 6550--Abbott Architect i1000 Reagents |
|---|---|
| Solicitation number | 36C26227Q0073 |
| Agency | Department of Veterans Affairs |
| Office | 262-Network Contract Office 22 (36C262) |
| Notice type | Solicitation |
| Set-aside | Small business |
| Trade (NAICS) | In-Vitro Diagnostic Substance Manufacturing (325413) |
| Product or service code | 6550 |
| Place of performance | Tucson, Arizona |
| Posted | Nov 10, 2026 |
| Response deadline | Nov 13, 2026, 1:00 AM (UTC-8) (2 days left) |
| Add the deadline to | Google Calendar · Apple / Outlook (.ics) |
Bid documents (8)
- Bid document 99 KB
- Bid document 14 KB
- Attachment A - Salient Characteristics 23 KB
- 0001 AMENDMENT 27 KB
- Bid document 15 KB
- Bid document 100 KB
- Attachment A - Salient Characteristics v2 24 KB
- Vendor Questions - Request for Quotations 12 KB
Paid members download every document from this page, or buy this bid alone.
Federal prevailing wage rates for this place: Arizona Davis-Bacon and SCA wage determinations.
Description
Combined synopsis/solicitation for Immunoassay Reagents, Supplies and Consumables to be used for patient testing on an existing Architect i1000 analyzer located at the Pathology and Laboratory Medicine Services in Southern Arizona VA Medical Center (VA Tucson).
Contracting contact
- Samuel Han · Contract Specialist · [email protected] · 562-766-2314
As published on the official notice. Ask questions in writing and before any questions deadline the notice sets.
Is your business small enough?
For NAICS 325413, a business counts as small if it has no more than 1,250 employees (SBA size standard). This notice is set aside, so only businesses under that size, or in the named program, can bid. SBA table, current as of Oct 15, 2026.
Notice history
- Oct 30, 2026: Solicitation Due Nov 13, 2026, 1:00 PM (UTC-8)
Companies that win this kind of work
Federal contractors paid for in-vitro diagnostic substance manufacturing work, who also hold VA contracts (last 12 months): possible competitors, or partners to team with.
- Cepheid $34.9 million in this trade
- Biomerieux Inc $34.6 million in this trade
- Roche Diagnostics Corporation $20.9 million in this trade
- Abbott Laboratories Inc. $4.8 million in this trade
- Quest Diagnostics Incorporated $4.4 million in this trade
About the buyer
The Department of Veterans Affairs awarded $83.7 billion in contracts in the last 12 months; its biggest suppliers were Optum Public Sector Solutions, Inc., Mckesson Corporation and Triwest Healthcare Alliance Corp. See what VA is buying now.
Who can bid: Small Business set-aside
Total and partial small business set-asides are open to any business under the SBA size standard for the notice's NAICS code.
All open Small Business set-asides.
In-Vitro Diagnostic Substance Manufacturing contracts right now
There are 20 open government contract opportunities in this trade (NAICS 325413), 10 posted in the last 7 days; 55% are set aside for small businesses. The agencies buying the most are Department of Veterans Affairs, Defense Health Agency (DHA) and National Institutes of Health. Most of the work with a stated place is in Maryland, Texas and Arizona. A notice in this trade gives a median of 15 days from posting to deadline; this one gives 3 days.
All open in-vitro diagnostic substance manufacturing contracts
Coming up in this trade
Planned contracts from the agencies' procurement forecasts, often months before a solicitation. Plans can change.
Recent awards in this trade
- Alba Bioscience, Inc. $11.0 million · Department of Veterans Affairs · Nov 2, 2026
- Abbott Molecular Inc. $919,866 · Department of Veterans Affairs · Oct 6, 2026
- Werfen USA LLC $345,941 · Department of Veterans Affairs · Oct 1, 2026
- Werfen USA LLC $69,188 · Department of Veterans Affairs · Oct 1, 2026
- Biomerieux Inc $284,026 · Department of Veterans Affairs · Oct 1, 2026
From the award notices agencies publish.